medigraphic.com
ISSN 1561-3194 (Electronic)

2014, Number 6

<< Back Next >>

Rev Ciencias Médicas 2014; 18 (6)

Associated risk factors and prevalence of metabolic syndrome in old people

Fonte MN, Sanabría NJG, Bencomo FLM, Fonte MA, Rodríguez NIL

Language: Spanish
References: 15
Page: 963-973
PDF size: 158.40 Kb.


ABSTRACT

Introduction: the set of risk factors which may lead to ischemic heart failure, diabetes and diseases related to overweight is known as metabolic syndrome.
Objective: to determine the presence of risk factors related to metabolic syndrome and its prevalence in old people.
Material and methods: an observational, descriptive and cross sectional study was carried out in subjects from 60 years old or older attending to two doctors’ offices at "Luis Augusto Turcios Lima" university polyclinic in Pinar del Río.
Results: hypertension and diabetes mellitus developed in the 60% of old people included in the investigation and coexisting in 19.2% of them. Hypertension and ischemic heart disease showed no significant differences in both sexes. Diabetes mellitus prevailed in female sex. Obesity, diabetes and hypertension did not have any association. Prevalence of metabolic syndrome was 78.9% in female sex, while in males 52.3%, significantly higher among female population, which increased with age. The comparison in each group of ages, according to sex, was significant for the group of 60-64 years old, female population showed a greater prevalence concerning metabolic syndrome.
Conclusions: a high figure of hypertensive patients with cardiovascular disease and diabetes was detected. Considering each metabolic disorders, as it is usually associated with metabolic syndrome, it is necessary learning about their correlation for not treating them separately. Its prevalence increases with age.


REFERENCES

  1. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older. Diabetes 2003; 52: 1210-14.

  2. Muñoz Batista MJ, Peña Borrego M, Hernández Gárciga FF, Pérez Lemus JF, Soler Tejera I, Just Matos CC. Síndrome metabólico en pacientes diabéticos tipo 2 pertenecientes al área de salud Guanabo. Rev Cubana Med Gen Integr. 2010 Jun; 26(2).

  3. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, FruchartJ C, James WP, Loria CM, Smith SC. Harmonizing the metabolic syndrome:a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16):1640-1645.

  4. Rodríguez Cabrera A, Álvarez Vázquez L, Castañeda Abascal I. La pirámide de población: Precisiones para su utilización. Rev Cubana Salud Pública. 2007 Dic; 33(4).

  5. Mozaffarian D, Kamineni A, Prineas R. Metabolic Syndrome and Mortality in Older Adults. Arch Intern Med. 2008; 168; 969-978.

  6. Tian N, Moore RS, Braddy S, Rose RA, Gu JW, Hughson MD, Manning RD. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 2007; 293(6).

  7. Alberti KG, Zimmet P.The metabolic syndrome a new worl wide definition from the international diabetes federation consensus. Lancet. 2005; 366:1059-62.

  8. Deurenberg P, Yap M. Body mass index and percent body fat. A meta analysis among different ethnic group. Int J Obes. 1998; 22:1164-1171.

  9. Díaz Díaz O, Orlando González N. Manual para el diagnóstico y tratamiento del paciente diabético a nivel primario de salud. La Habana: OPS/OMS; 2011.

  10. Jeffrey SF, Maratos-Flier E. Enfermedades del aparato cardiovascular. Enfermedades vasculares. Patogenia de la ateroesclerosis. En: Harrisons Principios de Medicina Interna. 16 Edición; 2011. Cap. 224.

  11. Masson W, Siniawski D, Krauss J, Cagide A. Clinical Applicability of the Framingham 30-Year Risk Score. Usefulness in Cardiovascular Risk Stratificationand the Diagnosis of Carotid Atherosclerotic Plaque. Rev Esp Cardiol 2011; 64(4):305- 311.

  12. Reaven GM. Relationships among insulin resistan-ce, type 2 diabetes, essential hypertension, and cardio-vascular disease: similarities and differences. J Clin Hypertens(Greenwich). 2011; 13(4): 238-43. Revista de Ciencias Médicas de Pinar del Río. 2014; 18(6): 963-973

  13. Rueda Alfaro S, et al. Síndrome metabólico y enfermedad cardiovascular en ancianos: resultados del Estudio de Envejecimiento de Mataró Med Clin(Barc). 2008; 130: 327-31.

  14. Jesús D. Hernández JD, Alfieri AB, Hoffmann IS, Ramírez A. Factores de riesgo del síndrome metabólico asociados al incremento de la natriuresis Revista Latinoamericana de Hipertensión. 2012; 7(3).

  15. Park J, Mendoza JA, O'Neil CE, Hilmers DC, Liu Y, Nicklas TA. A comparison of the prevalence of the metabolic syndrome in the United States (US) and Korea in young adults aged 20 to 39 years J Clin Nutr. 2008; 17(3): 471-482.




2020     |     www.medigraphic.com